# Crinetics Pharmaceuticals, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:a6345ead-3e9e-41ff-9720-b7828407f15a | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/crinetics-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-14T14:38:06.015003+00:00 | | Last reviewed | 2026-09-14T14:38:06.015003+00:00 | ## Identity - Legal name: Crinetics Pharmaceuticals, Inc. - Display name: Crinetics Pharmaceuticals, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-20T20:24:57.029386+00:00 | | Completeness | 0.409 | | Record Quality | 0.811 | | Directors | 13 | | Committees | 1 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Camille Bedrosian: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:6 - Caren Deardorf: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:8 - Matthew K. Fust: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:9 - Rogério Vivaldi Coelho: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:11 - Stephanie S. Okey: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:13 - Wendell Wierenga: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:15 - Weston Nichols: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:16 - Camille Bedrosian, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:7 - R. Scott Struthers, Ph.D.: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:10 - Rogério Vivaldi Coelho, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:12 - Stephanie S. Okey, M.S.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:14 - Wendell Wierenga, Ph.D.: Chairperson of the Board of Directors. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:5 - Weston Nichols, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:17 ## Committees - Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: R. Scott Struthers, Ph.D. (member, unknown). committee_id=alpha:committee:crinetics-pharmaceuticals-inc:chief-executive-officer-and-director ## Executive leadership - Dana Pizzuti, M.D.: Chief Medical and Development Officer. Status: unknown. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:18 - Isabel Kalofonos: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:19 - Jeff Knight: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:20 - R. Scott Struthers, Ph.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:21 - Stephen F. Betz, Ph.D.: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:22 - Tobin Schilke: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:23 ## Governance events - DIRECTOR_APPOINTED: Caren Deardorf seat on Crinetics Pharmaceuticals, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-09-14T14:38:06.015003+00:00. event_id=alpha:event:transition:2orc9w1ldus4c - DIRECTOR_APPOINTED: Rogério Vivaldi Coelho seat on Crinetics Pharmaceuticals, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-09-14T14:38:06.015003+00:00. event_id=alpha:event:transition:8juwe615ykivk - DIRECTOR_APPOINTED: Camille Bedrosian seat on Crinetics Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-09-14T14:38:06.015003+00:00. event_id=alpha:event:transition:qv2fra13qcwlw - DIRECTOR_APPOINTED: Stephanie S. Okey seat on Crinetics Pharmaceuticals, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-09-14T14:38:06.015003+00:00. event_id=alpha:event:transition:1uwvnba3f81ly - DIRECTOR_APPOINTED: Matthew K. Fust seat on Crinetics Pharmaceuticals, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-09-14T14:38:06.015003+00:00. event_id=alpha:event:transition:1d5lxc6g2q0zs - DIRECTOR_APPOINTED: Weston Nichols seat on Crinetics Pharmaceuticals, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-09-14T14:38:06.015003+00:00. event_id=alpha:event:transition:1cktwgc1dzstq - DIRECTOR_APPOINTED: Wendell Wierenga seat on Crinetics Pharmaceuticals, Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-09-14T14:38:06.015003+00:00. event_id=alpha:event:transition:1f87nj0ncwpmc ## Scoped resources - `alpha://company/crinetics-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record - `alpha://company/crinetics-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/crinetics-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/crinetics-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=board - `alpha://company/crinetics-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/crinetics-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/crinetics-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/crinetics-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/crinetics-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/crinetics-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/crinetics-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/crinetics-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/crinetics-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/crinetics-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/crinetics-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/crinetics-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/crinetics-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/crinetics-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/crinetics-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/crinetics-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=events - `alpha://company/crinetics-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/crinetics-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/crinetics-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Wendell Wierenga, Ph.D.: Chairperson of the Board of Directors. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Camille Bedrosian: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1112608398f14321843c5595407c4c8c634879fedd6d6e84a331d326a63ec61. - Camille Bedrosian, M.D.: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Caren Deardorf: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:8. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1112608398f14321843c5595407c4c8c634879fedd6d6e84a331d326a63ec61. - Matthew K. Fust: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:9. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1112608398f14321843c5595407c4c8c634879fedd6d6e84a331d326a63ec61. - R. Scott Struthers, Ph.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Rogério Vivaldi Coelho: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:11. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1112608398f14321843c5595407c4c8c634879fedd6d6e84a331d326a63ec61. - Rogério Vivaldi Coelho, M.D.: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Stephanie S. Okey: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:13. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1112608398f14321843c5595407c4c8c634879fedd6d6e84a331d326a63ec61. - Stephanie S. Okey, M.S.: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Wendell Wierenga: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:15. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1112608398f14321843c5595407c4c8c634879fedd6d6e84a331d326a63ec61. - Weston Nichols: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:16. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1112608398f14321843c5595407c4c8c634879fedd6d6e84a331d326a63ec61. - Weston Nichols, Ph.D.: Director. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Dana Pizzuti, M.D.: Chief Medical and Development Officer. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Isabel Kalofonos: Chief Commercial Officer. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Jeff Knight: Chief Operating Officer. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - R. Scott Struthers, Ph.D.: President and Chief Executive Officer. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Stephen F. Betz, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. - Tobin Schilke: Chief Financial Officer. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Crinetics Pharmaceuticals, Inc.. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a363857849321246f3d44ad951142e940ac4f02fb361f79ef7ad4e3605549e12. ## Entity Status - Public listing published. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a363857849321246f3d44ad951142e940ac4f02fb361f79ef7ad4e3605549e12. ## Published Fact - US. Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a363857849321246f3d44ad951142e940ac4f02fb361f79ef7ad4e3605549e12. ## Security Listing - CRNX (NASDAQ). Claim: alpha:claim:company:a6345ead-3e9e-41ff-9720-b7828407f15a:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a363857849321246f3d44ad951142e940ac4f02fb361f79ef7ad4e3605549e12. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:a363857849321246f3d44ad951142e940ac4f02fb361f79ef7ad4e3605549e12: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc). - alpha:projection-evidence:document:8d99ff3609f6b2afbac61de710d6da94b1a291cc8028464928bb060b2ff0fd4c: [SEC DEF 14A 0001658247-26-000030](https://www.sec.gov/Archives/edgar/data/1658247/000165824726000030/crnx-20260429.htm). - alpha:projection-evidence:document:a1112608398f14321843c5595407c4c8c634879fedd6d6e84a331d326a63ec61: [DEF 14A crnx-20260429.htm](https://www.sec.gov/Archives/edgar/data/1658247/000165824726000030/crnx-20260429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/crinetics-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/crinetics-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/crinetics-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/crinetics-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-20T20:24:56.830211+00:00; recorded 2026-10-20T20:24:56.830211+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.